Futura Medical Plc (FUM):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Futura Medical Plc (FUM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10139
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Futura Medical Plc (Futura Medical) is a pharmaceutical company that focuses on research and development of novel products for various therapeutic areas, including sexual health and pain relief management. The company focuses on developing pharmaceutical products based on its transdermal drug delivery system, DermaSys. It has products in the development pipeline for sexual healthcare and pain relief management. The company has partnerships with major pharmaceutical and healthcare companies such as Ansell Limited, Bizzy Diamond Heathcare and RFSU, among others for the distribution and development of its products. The company carries out its development operations through its wholly owned subsidiary, Futura Medical Developments Limited. Futura Medical is headquartered in Surrey, the UK.

Futura Medical Plc (FUM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Futura Medical Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Futura Medical Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Futura Medical Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Futura Medical Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Futura Medical Plc, Medical Devices Deals, 2012 to YTD 2018 9
Futura Medical Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Futura Medical Plc, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
F Lima Enters into Licensing Agreement with Futura Medical 11
Thornton & Ross Enters into Licensing Agreement with Futura Medical 12
Milsing Enters into Licensing Agreement with Futura Medical 13
TTK Protective Devices Enters into Licensing Agreement with Futura Medical 14
Quantum Pharma Enters into Licensing Agreement with Futura Medical 15
Futura Medical Enters Into Licensing Agreement With Ansell For CSD500 In China 16
Futura Medical Enters Into Licensing Agreement With RFSU For CSD-500 17
Equity Offering 18
Futura Medical Raises USD7.4 Million in Private Placement of Shares 18
Futura Medical to Raise up to USD1.3 Million in Rights Offering of Shares 19
Futura Medical Raises USD14.6 Million in Private Placement of Shares 20
Futura Medical Announces Private Placement Of Shares For US$20 Million 21
Futura Medical Plc – Key Competitors 22
Futura Medical Plc – Key Employees 23
Futura Medical Plc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Sep 26, 2018: Futura Medical: Interim Results for the six months ended 30 June 2018 25
Mar 14, 2018: Futura Medical: Preliminary Results for the year ended 31 December 2017 29
Sep 12, 2017: Futura Medical: Interim Results for the six months ended 30 June 2017 33
Mar 23, 2017: Futura Medical: Preliminary Results for the year ended 31 December 2016 34
Corporate Communications 35
Feb 20, 2018: Futura Medical: Directorate Changes 35
Other Significant Developments 36
Sep 19, 2018: Futura Medical provides business update 36
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Futura Medical Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Futura Medical Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Futura Medical Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Futura Medical Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Futura Medical Plc, Deals By Therapy Area, 2012 to YTD 2018 8
Futura Medical Plc, Medical Devices Deals, 2012 to YTD 2018 9
Futura Medical Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
F Lima Enters into Licensing Agreement with Futura Medical 11
Thornton & Ross Enters into Licensing Agreement with Futura Medical 12
Milsing Enters into Licensing Agreement with Futura Medical 13
TTK Protective Devices Enters into Licensing Agreement with Futura Medical 14
Quantum Pharma Enters into Licensing Agreement with Futura Medical 15
Futura Medical Enters Into Licensing Agreement With Ansell For CSD500 In China 16
Futura Medical Enters Into Licensing Agreement With RFSU For CSD-500 17
Futura Medical Raises USD7.4 Million in Private Placement of Shares 18
Futura Medical to Raise up to USD1.3 Million in Rights Offering of Shares 19
Futura Medical Raises USD14.6 Million in Private Placement of Shares 20
Futura Medical Announces Private Placement Of Shares For US$20 Million 21
Futura Medical Plc, Key Competitors 22
Futura Medical Plc, Key Employees 23
Futura Medical Plc, Subsidiaries 24

List of Figures
Futura Medical Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Futura Medical Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Futura Medical Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Futura Medical Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Futura Medical Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Futura Medical Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Futura Medical Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Futura Medical Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Futura Medical Plc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Futura Medical Plc (FUM):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • South Texas Accelerated Research Therapeutics:製薬・医療:M&Aディール及び事業提携情報
    Summary South Texas Accelerated Research Therapeutics (START) accelerates the development of novel anticancer agents that improves personalized and clinical care for cancer patients. The company offers preclinical and clinical research services which include pharmacokinetics, in vivo and in vitro se …
  • Eli Lilly and Co (LLY):医療機器:M&Aディール及び事業提携情報
    Summary Eli Lilly and Co (Lilly) is a healthcare company that discovers, develops and markets human and animal healthcare products. The company offers medicines for cardiovascular conditions, diabetes, cancer, neurological problems, immune disorders, men's health and musculoskeletal problems. It als …
  • Navidea Biopharmaceuticals Inc (NAVB):医療機器:M&Aディール及び事業提携情報
    Summary Navidea Biopharmaceuticals Inc (Navidea) is a biopharmaceutical company that develops precision immunodiagnostic agents and immunotherapeutics.. The company is focused on developing multiple precision-targeted products based on its Manocept platform to improve patient care. Its pipeline prod …
  • Hess Corp (HES):電力:M&Aディール及び事業提携情報
    Summary Hess Corp (Hess) is a global independent energy company which carries out the exploration and production of crude oil and natural gas. It primarily operates in US, Denmark, the Joint Development Area of Malaysia/Thailand (JDA), and Malaysia. It offers fee-based services including gathering, …
  • China Resources Pharmaceutical Group Ltd (3320):製薬・医療:M&Aディール及び事業提携情報
    Summary China Resources Pharmaceutical Group Ltd (CR Pharma), a subsidiary of China Resources (Holdings) Co Ltd is a pharmaceutical company that offers nutritional supplements. The company offers research and development, manufacture, and distribution of whole drug products. Its products comprise ch …
  • Foodwell Corporation:企業の戦略・SWOT・財務分析
    Foodwell Corporation - Strategy, SWOT and Corporate Finance Report Summary Foodwell Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • CESC Limited:企業の戦略・SWOT・財務分析
    CESC Limited - Strategy, SWOT and Corporate Finance Report Summary CESC Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Telekom Malaysia Berhad (TM):企業の財務・戦略的SWOT分析
    Telekom Malaysia Berhad (TM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • E.Sun Financial Holding Co Ltd:企業の戦略・SWOT・財務情報
    E.Sun Financial Holding Co Ltd - Strategy, SWOT and Corporate Finance Report Summary E.Sun Financial Holding Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Havfisk ASA:企業の戦略・SWOT・財務分析
    Havfisk ASA - Strategy, SWOT and Corporate Finance Report Summary Havfisk ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Carmell Therapeutics Corp:企業の製品パイプライン分析2018
    Summary Carmell Therapeutics Corp (Carmell) is a biotechnology company that develops and commercializes bone healing accelerants and tissue healing accelerants. Its pipeline portfolio include adjunctive treatment for long bone fractures in Phase I and Phase II a; and adjunctive treatment for total j …
  • Edison International (EIX):企業の財務・戦略的SWOT分析
    Edison International (EIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Scynexis Inc (SCYX):製薬・医療:M&Aディール及び事業提携情報
    Summary Scynexis Inc (Scynexis) is a pharmaceutical company that discovers, develops and commercializes novel anti-infective for various therapeutic needs. The company provides pipeline products such as SCY-078, is used for invasive fungal infections; SCY-635, is used for the treatment of Hepatitis …
  • Tethys Petroleum Ltd (TPL.H):企業の財務・戦略的SWOT分析
    Tethys Petroleum Ltd (TPL.H) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Novelis Inc:企業の戦略・SWOT・財務分析
    Novelis Inc - Strategy, SWOT and Corporate Finance Report Summary Novelis Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • HiberGene Diagnostics Ltd:医療機器:M&Aディール及び事業提携情報
    Summary HiberGene Diagnostics Ltd (HiberGene Diagnostics) is a medical equipment company that manufactures, develops and markets molecular diagnostic tests for human infectious diseases using the LAMP technology. The company’s products include HG C. Difficile, HG Meningococcus, HG Group B Streptococ …
  • InsuLine Medical Ltd (INSL)-医療機器分野:企業M&A・提携分析
    Summary InsuLine Medical Ltd (InsuLine Medical) is a medical device company that develops, manufactures and markets device which enables patients on intensive insulin therapy. The company’s products include InsuPad and InsuPatch. Its InsuPad is a patch for syringes and insulin pens; and InsuPatch is …
  • Mazagon Dock Shipbuilders Ltd:戦略・SWOT・企業財務分析
    Mazagon Dock Shipbuilders Ltd - Strategy, SWOT and Corporate Finance Report Summary Mazagon Dock Shipbuilders Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Showa Sangyo Co., Ltd.:企業の戦略・SWOT・財務情報
    Showa Sangyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Showa Sangyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Park Group plc:企業の戦略・SWOT・財務情報
    Park Group plc - Strategy, SWOT and Corporate Finance Report Summary Park Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆